← Back to all trials
Not Yet Recruiting
NCT05624619
The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy
Conditions: Sepsis-induced Cardiomyopathy, Speckle Tracking Imagining, Tissue Motion Annular Displacement
Sex: All
Ages: 18 Years – N/A
Enrollment: 150
Sponsor: Shanghai Zhongshan Hospital
Summary
The aim of this study is to explore if STI technology, especially TMAD, plays an important role in evaluating left ventricular longitudinal systolic function and discriminating SICM in patients with sepsis.
We also intend to prove that TMAD may have predictive value in patients with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence for subsequent clinical practical applications.
Eligibility Criteria
Inclusion Criteria:patients who are diagnosed as sepsis according to sepsis 3.0 criteriaExclusion Criteria:patients with history of organic heart disease;patients with history of heart failureholder of cardiac implanted device;patients with history of atrial fibrillation;refusal to participate in the study
Source: ClinicalTrials.gov (NCT05624619). StuddyBuddy aggregates publicly available trial information.
